TEVA

Teva Pharmaceutical Industries Ltd Earnings

$13.43

Earnings Summary

Revenue	$4229Mn
Net Profits	$-217Mn
Net Profit Margins	-5.13%

Highlights

Revenue:

Teva Pharmaceutical Industries Ltd’s revenue fell -5.12% since last year same period to $4229Mn in the Q4 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -2.38% fall in its revenue since last 3-months.

Net Profits:

Teva Pharmaceutical Industries Ltd’s net profit fell -150.58% since last year same period to $-217Mn in the Q4 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 50.34% jump in its net profits since last 3-months.

Net Profit Margins:

Teva Pharmaceutical Industries Ltd’s net profit margin fell -153.31% since last year same period to -5.13% in the Q4 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 49.13% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Teva Pharmaceutical Industries Ltd post its latest quarter earnings

EPS Estimate Current Quarter	0.7
EPS Estimate Current Year	0.7

Highlights

EPS Estimate Current Quarter:

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.7 - a 8.06% jump from last quarter’s estimates.

EPS Estimate Current Year:

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.7.

Key Ratios

Key ratios of the Teva Pharmaceutical Industries Ltd post its Q4 2024 earnings

Earning Per Share (EPS)

0.71

Highlights

Earning Per Share (EPS):

Teva Pharmaceutical Industries Ltd’s earning per share (EPS) fell -29% since last year same period to 0.71 in the Q4 2024. This indicates that the Teva Pharmaceutical Industries Ltd has generated -29% annual rate of fall in its earning per share (EPS) in the last 4 quarters.